Dietary emulsifier consumption accelerates type 1 diabetes development in NOD mice

被引:0
作者
Clara Delaroque
Benoit Chassaing
机构
[1] Université Paris Cité,INSERM U1016, team “Mucosal microbiota in chronic inflammatory diseases”, CNRS UMR 8104
来源
npj Biofilms and Microbiomes | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The rapidly increasing prevalence of type 1 diabetes (T1D) underscores the role of environmental (i.e. non-genetic) determinants of T1D development. Such factors include industrialized diets as well as the intestinal microbiota with which they interact. One component of industrialized diets that deleteriously impact gut microbiota is dietary emulsifiers, which perturb intestinal microbiota to encroach upon their host promoting chronic low-grade intestinal inflammation and metabolic syndrome. Hence, we investigated whether 2 dietary emulsifiers, carboxymethylcellulose (CMC) and polysorbate-80 (P80), might influence the development of T1D in NOD mice, which spontaneously develop this disorder. We observed that chronic emulsifier exposure accelerated T1D development in NOD mice, which was associated with increased insulin autoantibody levels. Such accelerated T1D development was accompanied by compositional and functional alterations of the intestinal microbiota as well as low-grade intestinal inflammation. Moreover, machine learning found that the severity of emulsifier-induced microbiota disruption had partial power to predict subsequent disease development, suggesting that complex interactions occur between the host, dietary factors, and the intestinal microbiota. Thus, perturbation of host–microbiota homeostasis by dietary emulsifiers may have contributed to the post-mid-20th-century increase in T1D.
引用
收藏
相关论文
共 97 条
[21]  
Chassaing B(2015)Acute versus progressive onset of diabetes in NOD mice: potential implications for therapeutic interventions in type 1 diabetes Diabetes 64 3885-1302.e16
[22]  
Chassaing B(2022)The effect of spermidine on autoimmunity and beta cell function in NOD mice Sci. Rep. 12 9973-221
[23]  
Chassaing B(2015)Microbiota regulates type 1 diabetes through Toll-like receptors Proc. Natl Acad. Sci. USA 112 e75385-5922
[24]  
Van de Wiele T(2019)Toll-like receptor 4 inhibition prevents autoimmune diabetes in NOD mice Sci. Rep. 9 571-1624
[25]  
De Bodt J(2013)Toll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice PLoS ONE 8 e44328-857
[26]  
Marzorati M(2021)Direct impact of commonly used dietary emulsifiers on human gut microbiota Microbiome 9 983-583
[27]  
Gewirtz AT(2013)Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut Cell Host Microbe 14 1445-D596
[28]  
Srour B(2019)Flagellin-elicited adaptive immunity suppresses flagellated microbiota and vaccinates against chronic inflammatory diseases Nat. Commun. 10 1832-1080
[29]  
Patterson CC(2012)Fecal Lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation PLoS ONE 7 e0125448-235
[30]  
Marino M(2021)Inulin fermentable fiber ameliorates type I diabetes via IL22 and short-chain fatty acids in experimental models Cell. Mol. Gastroenterol. Hepatol. 12 1291-undefined